Pure Global
NCT05972850

Vivo Heart: Home-Based Virtual Exercise Program for Older Adults With Cardiovascular Disease

Wake Forest University Health Sciences·ClinicalTrials.gov·behavioralNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Cardiovascular Disease
Drug/Device/Intervention
Vivo Heart
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Wake Forest University Health Sciences
Location
Winston-Salem, United States of America
Timeline & enrollment
Phase
N/A
Start date
Sep 01, 2023
End date
Jul 01, 2024
Enrollment
40 participants
Primary outcome

Completion Rate

Summary

This pilot study will assess the feasibility and generate preliminary efficacy data of a
 novel, synchronous, home-based exercise training program for rural older adults with
 cardiovascular disease (CVD) using Vivo, an online, live, small group fitness program
 developed for older adults. It uses individually tailored dual-tasked (i.e., cognitive-motor)
 exercises to improve strength, endurance, balance, and cognition and incorporates social
 engagement. Certified trainers deliver instruction and coaching through an interactive
 session (45 min, 2-3 times/week) delivered over 12 weeks. Vivo Heart adapts this unique
 program to meet the cardiac rehabilitation needs of older adults with CVD. The specific aims
 are to evaluate the feasibility, acceptability, and uptake of Vivo Heart (Aim 1) and obtain
 pre- and post-intervention measures of exercise capacity, strength, lower-extremity physical
 function, cognition, quality of life, stress, fatigability, physical activity, and aging
 biomarkers (Aim 2).

ICD-10 classifications
Cardiovascular disease, unspecifiedHypertensive heart diseaseHeart disease, unspecifiedAtherosclerotic cardiovascular disease, so describedAtherosclerotic heart disease
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05972850
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05972850 through Pure Global AI's free database. This phase not specified trial is sponsored by Wake Forest University Health Sciences and is currently Not yet recruiting. The study focuses on Cardiovascular Disease. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.